Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CardioComm Solutions Inc V.EKG

Alternate Symbol(s):  EKGGF

Healthcare Medical Devices
CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The Company is also engaged in manufacturing, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It has developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.


TSXV:EKG - Post by User

CardioComm Solutions Inc > Quarter 3 report
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by word99on Dec 01, 2020 8:10pm
223 Views
Post# 32015276

RE:Quarter 3 report

RE:Quarter 3 reportThis says it best. (You need to read between the lines for future news releases that are pending) 


To  reduce  dependency  on NRE  revenue  for  reaching  profitability,  the Company  has executed  on  several  comarketing,  sales and  partnership agreements with  telemedicine  platforms and hardware manufacturers to yield new revenue from the sale of wireless HeartCheck™ Branded ECG devices,  GEMS™  software  licensing,  GEMS™  Mobile  Smartphone  app  downloads  and  from  ECG  paid  for  reading  services.  The  Company secured key FDA clearance in early 2019 which will form the basis of many of the new revenue opportunities. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities